Turnover: 700000 EUR (2019)

Country: France

We are an innovative clinical-stage gene therapy company dedicated to the discovery, development and commercialization of innovative therapies for patients with severe neurodegenerative diseases of the retina.

Studies mentioning this company

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.